{"schema_version":"secwatch.filing_event.v1","accession":"0001770141-24-000089","form_type":"8-K","ticker":null,"cik":"0001770141","company_name":"UpHealth, Inc.","filed_at":"2024-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.469187+00:00","generated_at":"2026-05-31T20:43:58.023988+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"UpHealth CEO Martin Beck resigns; CFO Jay Jennings appointed Acting CEO","bullets":["Martin Beck resigned as CEO and Class I director effective July 10, 2024; no disagreements cited.","Board appointed CFO Jay Jennings as Acting CEO, effective July 11, 2024, retaining CFO role.","Lisa Fluxman promoted to President of TTC Healthcare; Jeremy Livianu reaffirmed as CLO/Secretary.","Company is now delisted from NYSE (June 2024) and trades OTC under ticker UPHL."],"urls":{"canonical":"https://secwatch.observer/filing/0001770141-24-000089","json":"https://secwatch.observer/filing/0001770141-24-000089.json","markdown":"https://secwatch.observer/filing/0001770141-24-000089.md","text":"https://secwatch.observer/filing/0001770141-24-000089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770141/000177014124000089/0001770141-24-000089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770141/000177014124000089/uph-20240710.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:43:58.023988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"228fd21098","claim":"Jay Jennings was appointed as Acting Chief Executive Officer at UpHealth, Inc..","evidence_excerpt":"the Board appointed Jay Jennings, the Company’s Chief Financial Officer, to serve as the Acting Chief Executive Officer of the Company effective upon the termination of Mr. Beck as Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770141/000177014124000089/0001770141-24-000089-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Acting Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"562983a96e","claim":"Martin Beck resigned as Chief Executive Officer at UpHealth, Inc..","evidence_excerpt":"On July 10, 2024, Martin Beck submitted a letter of resignation to the Chairman of the Board of Directors (the “Board”) of UpHealth, Inc. (the “Company”) from his positions as the Chief Executive Officer of the Company and all subsidiaries of the Company for which he serves as Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770141/000177014124000089/0001770141-24-000089-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"cfbeb6dd62","claim":"Martin Beck resigned as Class I Director at UpHealth, Inc..","evidence_excerpt":"he is resigning from his position as a Class I director of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770141/000177014124000089/0001770141-24-000089-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}